Democrats plan an unusual Sunday teleconference to map strategy around Rep. Thomas Massie’s amendment to a fiscal 2027 State Department/foreign aid bill that would end Israel military aid and cut the overall foreign aid program by $3.3 billion, signaling sharp caucus divisions ahead of a potential floor vote next week; Republicans have not yet scheduled a vote.
After Elon Musk’s Department of Government Efficiency cut USDA funding for screwworm control, the Trump administration ordered at least $1 billion to combat an outbreak spreading into Texas and New Mexico, including plans for a Texas facility to release hundreds of millions of sterile flies by 2027. Critics say the DOGE-driven cuts undermined surveillance and staffing, paused foreign facilities, and will cost taxpayers while beef prices rise.
The House approved a bipartisan Ukraine security aid package totaling more than $8 billion—the strongest measure in over a year—over GOP leadership objections, after six Republicans broke ranks to force a vote. The package includes loans for military equipment and sanctions on Russia, and now moves to the Senate.
The House approved a package to fund Ukraine and to impose sanctions on Russia, signaling bipartisan support for Kyiv and a tougher stance on Moscow, even as it challenged Donald Trump’s position.
The Trump administration plans to quarantine Americans exposed to Ebola at a U.S.-run field hospital in central Kenya, with the military directed to stand it up within a week, prompting concerns about health worker training and care and reflecting resistance to repatriating exposed Americans.
Official data show PEPFAR kept about 20 million people on HIV treatment in mid-2025, but prevention work deteriorated sharply: roughly 4 million fewer people were tested in Q4 2025, new treatment starts fell, PrEP enrollments dropped about 41%, and prevention programs for key populations collapsed to near zero, all amid workforce cuts and less transparent reporting—raising concerns of a hidden, long-term HIV surge despite seemingly steady treatment numbers.
The Pentagon is considering shifting weapons meant for Ukraine to the Middle East due to depleted U.S. munitions from the Iran conflict, highlighting growing trade‑offs as Washington seeks to sustain aid to Ukraine while replenishing stockpiles.
Four years into Russia’s invasion of Ukraine, the war shows little sign of ending, with massive casualties, widespread displacement, and only modest battlefield gains. CSIS estimates up to 1.8 million military casualties across both sides (Russia ~1.2 million; Ukraine ~500,000–600,000). Civilian tolls include about 15,000 dead and more than 40,000 injured, with 2,514 civilian deaths in 2025 alone. About 5.9 million Ukrainians have fled abroad and millions more are displaced internally; Russia occupies roughly 19.4% of Ukrainian land, up from about 7% before the invasion. Foreign military aid to Kyiv fell ~13% in 2025 versus the 2022–24 average, though Europe stepped up while U.S. weapons funding waned. Health-care facilities have been hit in 2,881 attacks. The data underscore a grinding conflict with heavy costs and uncertain prospects for a breakthrough.
President Trump announced the U.S. will contribute $10 billion to a 'Board of Peace' he created for Gaza’s peace plan, with the funding source still unclear amid major cuts to foreign aid; the board’s scope and oversight of UN activities remain unclear even as a large U.S. military buildup and a looming decision on Iran’s nuclear program unfold.
One year after the Trump-era dismantling of USAID, a Lancet study projects that ongoing global aid cuts could cause about 9.4 million more deaths by 2030 (about 2.5 million under age 5) vs maintaining 2023 funding; deeper cuts could raise deaths to 22.6 million. Using data from 93 low- and middle-income countries, the analysis credits overseas aid with major declines in child mortality and infectious diseases, while warning that current and planned cuts are already weakening health systems as clinics close and mortality data gaps emerge. Some donors argue for reform of the aid system and route funds through recipient governments; the study notes it doesn’t fully account for philanthropic or national countermeasures that could mitigate harms.
Vice President JD Vance announced a sweeping expansion of the Mexico City Policy, extending the ban on U.S. non-military foreign assistance to any organization that works on abortion or promotes diversity, equity and inclusion and transgender issues abroad, effectively tripling the policy’s reach. The move, praised by anti-abortion activists and tied to the Trump administration’s effort to curb what it calls radical gender ideologies, drew criticism from humanitarian groups who warn it will limit women’s health services and civil society organizations overseas.
The Trump administration will broaden the Mexico City policy to bar recipients of U.S. foreign aid from promoting or supporting abortion and will extend the prohibition to include diversity, equity and inclusion programs and gender ideology, affecting more than $30 billion in aid and impacting both foreign and U.S.-based NGOs as well as international organizations.
Trump unveils a plan to condition U.S. foreign assistance on recipient countries' policies on abortion, diversity, equity and inclusion, and gender identity, signaling a sweeping shift in aid criteria.
Congress largely rejected President Trump’s request for deep, sweeping budget cuts, passing bipartisan funding bills that keep most federal programs funded and only modestly trim a few, including maintaining NASA and NSF funding and preserving Voice of America, the National Endowment for Democracy, and the National Endowment for the Arts. The House approved funding for State and Treasury and foreign aid with more than Trump’s request but below current levels, and eight of twelve appropriation bills have moved forward as lawmakers race toward a Jan. 30 deadline. The White House’s attempt to cancel IRS funding was blocked, while disagreements remain over Homeland Security and immigration policy.
Trump unveils an $11.1 billion, five-year “America First Global Health Strategy” to replace USAID by sending money directly to foreign governments, health organizations, and drug makers—primarily in Africa—with a focus on HIV/AIDS, malaria, TB, and maternal health, aiming to boost U.S. influence while bypassing NGOs, though critics warn of corruption and data-tracking risks.